Open AccessPlatelet function in diabetic and nondiabetic patients with chronic obstructive pulmonary disease: a case control study
Author(s) -
Makhlouf Hoda Ahmed,
Sadek Samiaa Hamdy,
Nafady Asmaa Abdel Hakim
Publication year - 2018
Publication title -
the clinical respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.789
H-Index - 33
eISSN - 1752-699X
pISSN - 1752-6981
DOI - 10.1111/crj.12477
Subject(s) - medicine , copd , mean platelet volume , platelet , diabetes mellitus , c reactive protein , platelet activation , gastroenterology , systemic inflammation , pulmonary function testing , cardiology , inflammation , endocrinology
Abstract Background The effect of association between chronic obstructive pulmonary disease (COPD) and diabetes (DM) on platelet function has not been studied before. Objectives To evaluate the effect of the association between COPD and DM on platelet function and C reactive protein (CRP). Patients and Methods This case control study was carried out on 110 stable COPD patients who were classified into diabetic and nondiabetic groups. In addition, 40 apparently healthy, age and sex‐matched individuals were included in this study as a control group. Chest X‐ray, pulmonary function testing and arterial blood gases were done for COPD patients. CRP and complete blood count (CBC) were measured in both patient and control groups. Results Mean platelet volume (MPV), platelet distribution width (PDW), platelet crit (PCT) and CRP were significantly higher in COPD patients either nondiabetic or diabetic compared to control group. Moreover, MPV and CRP markers were significantly higher in COPD diabetic patients compared to nondiabetic. There was no significant difference in various laboratory data among different stages of COPD either diabetic or nondiabetic ( P > 0.05). In COPD patients, MPV was a significantly positively correlated with CRP and PDW ( r = 0.346, P < 0.001; r = 0.510, P < 0.001, respectively) and negatively correlated with PLT count ( r = −0.294, P = 0.002). Conclusion MPV, PDW, PCT and CRP were significantly higher in COPD patients either nondiabetic or diabetic. Platelet function may be modified by the systemic inflammation that associated with COPD. Platelet activation as a prothrombotic sequence of this disease may be used as novel therapeutic target.